BridgeMD
New treatment option for Tuberculosis
Official title Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
ClinicalTrials.gov ID: NCT05917210
What this study is testing
- What it's testing
- This cluster-randomized trial in Uganda will evaluate the effectiveness and implementation of a novel, peer-led TB education and counseling strategy to improve outcomes among persons with tuberculosis (TB) with and without HIV/AIDS and assess the social-behavioral mechanisms underlying the observed treatment effects.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥18 years
- Registered as a new, relapse, treatment failure, or previously lost-to-follow-up
- TB case according to the on-site NTP TB Treatment Register
- Screened and invited to participate within 30 days of TB treatment initiation
You likely can't join if
- Diagnosed with possible or confirmed drug-resistant TB
- Transferring TB care into the clinic from an off-site facility
- Residing \>40 km from the enrolling clinic
- Lacking mental capacity to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Kampala, Uganda
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kampala, Uganda. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.